Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for Tennessee by County

Non-Hodgkin Lymphoma (All Stages^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Name

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


Tennessee6


US (SEER+NPCR)1


Wilson County6


Williamson County6


White County6


Weakley County6


Wayne County6


Washington County6


Warren County6


Union County6


Unicoi County6


Tipton County6


Sumner County6


Sullivan County6


Stewart County6


Smith County6


Shelby County6


Sevier County6


Sequatchie County6


Scott County6


Rutherford County6


Robertson County6


Roane County6


Rhea County6


Putnam County6


Polk County6


Overton County6


Obion County6


Morgan County6


Montgomery County6


Monroe County6


McNairy County6


McMinn County6


Maury County6


Marshall County6


Marion County6


Madison County6


Macon County6


Loudon County6


Lincoln County6


Lawrence County6


Lauderdale County6


Knox County6


Johnson County6


Jefferson County6


Humphreys County6


Hickman County6


Henry County6


Henderson County6


Hawkins County6


Hardin County6


Hardeman County6


Hamilton County6


Hamblen County6


Grundy County6


Greene County6


Grainger County6


Giles County6


Gibson County6


Franklin County6


Fentress County6


Fayette County6


Dyer County6


Dickson County6


Decatur County6


DeKalb County6


Davidson County6


Cumberland County6


Crockett County6


Coffee County6


Cocke County6


Claiborne County6


Cheatham County6


Carter County6


Carroll County6


Cannon County6


Campbell County6


Bradley County6


Blount County6


Benton County6


Bedford County6


Anderson County6


Bledsoe County6 Chester County6 Clay County6 Hancock County6 Haywood County6 Houston County6 Jackson County6 Lake County6 Lewis County6 Meigs County6 Moore County6 Perry County6 Pickett County6 Trousdale County6 Van Buren County6

Notes:
Created by statecancerprofiles.cancer.gov on 12/05/2024 3:21 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. The Average Annual Percent Change (AAPC) is based on the APCs calculated by Joinpoint. Due to data availability issues, the time period used in the calculation of the joinpoint regression model may differ for selected counties.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) Summary/Historic Combined Summary Stage (2004+).
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Φ Rural-Urban Continuum Codes provided by the USDA.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).
1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used with SEER November 2023 data.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.